Obesity is the excessive or abnormal accumulation of fat or adipose tissue in the body that may impair health. Obesity has become an epidemic which has worsened for the last 50 years. In the United States, the economic burden is estimated to be about $100 billion annually. Obesity is a complex disease and has multifactorial etiology. It is the second most common cause of preventable death after smoking. Obesity is associated with multiple medical conditions and can cause serious complications of chronic conditions. Obesity needs multiprong treatment strategies and may require lifelong treatment. A 5% to 10% weight loss can significantly improve health, quality of life, and economic burden of an individual and a country as a whole.
Obesity is the result of an imbalance between daily energy intake and energy expenditure resulting in excessive weight gain. Obesity is caused by multiple factors which can be genetic, cultural, and societal can be considered common. Other causes of obesity include reduced physical activity, insomnia, food habits, endocrine disorders, medications, food advertisements, and energy metabolism.
Most common syndromes associated with obesity include Prader Willi syndrome and MC4R syndromes, others like fragile X, Bardet-Beidl syndrome, Wilson Turner congenital leptin deficiency, and Alstrom syndrome are also associated with obesity.
Nearly one-third of adults and about 17% of adolescents in the United States are obese. According to Center for Disease Control and Prevention (CDC), 2011 to 2012 data, one out of five adolescents, one out of six elementary school age children, and one out of 12 preschool age children are obese. Obesity is more prevalent in African Americans, followed by Hispanics and whites. Southern US states have the highest prevalence, followed by the Midwest, Northeast and the west.
Obesity is associated with cardiovascular disease, dyslipidemia, and insulin resistance, in turn, causing diabetes, stroke, gallstones, fatty liver, obesity hypoventilation syndrome, sleep apnea, and cancers.
Association of genetics and obesity is already well established by multiple studies. FTO gene is associated with adiposity. This gene might harbor multiple variants that increase the risk of obesity.
Leptin is an adipocyte hormone which reduces food intake and body weight. Cellular leptin resistance is associated with obesity. Adipose tissue secretes adipokines and free fatty acids causing systemic inflammation which causes insulin resistance and increased triglyceride levels, which subsequently contributes to obesity.
Obesity can cause increased fatty acid deposition in the myocardium causing left ventricular dysfunction. It has also been shown to alter renin-angiotensin system causing increasing salt retention and elevated blood pressure.
Adipocytes have been shown to have an inflammatory and prothrombotic activity which can increase the risk of strokes.
All children six years and older, adolescents, and all adults should be screened for obesity according to the United States Preventative Services Task Force (USPSTF) recommendations.
Physicians should carefully screen for underlying causes contributing to obesity. A complete history should include:
Complete Physical examination Should be done and should include body mass index (BMI) measurement, weight circumference, body habitus, vitals.
Obesity focus findings like acne, hirsutism, skin tags, acanthosis nigricans, striae, Mallampati scoring, buffalo hump, fat pad distribution, irregular rhythms, gynecomastia, abdominal pannus, hepatosplenomegaly, hernias, hypoventilation, pedal edema, varicoceles, stasis dermatitis, and gait abnormalities can be present.
A standard screening tool for obesity is the measurement of body mass index (BMI). BMI is calculated using weight in kilograms divided by the square of height in meters. Obesity can be classified according to BMI:
Waist to hip ratio should be measured, in men more than 1:1 and women more than 0:8 is considered significant.
Further evaluation studies like skinfold thickness, bioelectric impedance analysis, CT, MRI, DEXA, water displacement, and air densitometry studies can be done.
Laboratory studies include complete blood picture, basic metabolic panel, renal function, liver function study, lipid profile, HbA1C, TSH, vitamin D levels, urinalysis, CRP, other studies like ECG and sleep studies can be done for evaluating associated medical conditions.
Obesity causes multiple comorbid and chronic medical conditions, and physicians should have a multiprong approach in the management of obesity. Practitioners should individualize treatment, treat underlying secondary causes of obesity, and focus on managing or controlling associated comorbid conditions. Management should include dietary modification, behavior interventions, medications, and surgical intervention if needed.
Dietary modification should be individualized with close monitoring of regular weight loss. Low-calorie diets are recommended. Low calorie could be carbohydrate or fat restricted. A low-carbohydrate diet can produce greater weight loss in the first months compared to low-fat diet. The patient's adherence to their diet should frequently be emphasized.
Behavior Interventions: The USPSTF recommends obese patients to be referred to intensive behavior interventions. Several psychotherapeutic interventions are available which includes motivational interviewing, cognitive behavior therapy, dialectical behavior therapy, and interpersonal psychotherapy. Behavior interventions are more effective when they are combined with diet and exercise.
Medications: Antiobesity medications can be used for BMI greater than or equal to 30 or BMI greater than or equal to 27 with comorbidities. Medications can be combined with diet, exercise, and behavior interventions. FDA-approved antiobesity medications include phentermine, orlistat, lorcaserin, liraglutide, diethylpropion, phentermine/topiramate, naltrexone/bupropion, phendimetrazine. All the agents are used for long-term weight management. Orlistat is usually the first choice because of its lack of systemic effects due to limited absorption. Lorcaserin should be avoided with other serotonergic medications due to the risk of serotonin syndrome. High responders usually lose more than 5% weight in first three months.
Surgery: Indications for surgery are a BMI greater or equal to 40 or a BMI of 35 or greater with severe comorbid conditions. The patient should be compliant with post-surgery lifestyle changes, office visits, and exercise programs. Patients should have an extensive preoperative evaluation of surgical risks. Commonly performed bariatric surgeries include adjustable gastric banding, Rou-en-Y gastric bypass, and sleeve gastrectomy. Rapid weight loss can be achieved with gastric bypass, and it is the most commonly performed procedure. Early postoperative complications include leak, infection, postoperative bleeding, thrombosis, cardiac events. Late complications include malabsorption, vitamin and mineral deficiency, refeeding syndrome, dumping syndrome.
Management of obesity should also include prevention strategies with physical activity, exercise, nutrition, and weight maintenance.
The management of obesity is best done with a multidisciplinary team that includes a bariatric nurse, surgeon, internist, primary care provider, endocrinologist, and a pharmacist. The key is to educate the patient on the importance of changes in lifestyle. No intervention works if the patient remains sedentary. Even after surgery, some type of exercise program is necessary to prevent weight gain. So far there is no magic bullet to reverse obesity- all treatments have high failure rates and some like surgery also have life-threatening complications. Lifestyle changes alone can help obese people reverse the weight gain, but the problem is most people are not motivated to exercise.
|||Saalbach A,Anderegg U, Thy-1: more than a marker for mesenchymal stromal cells. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2019 Feb 27; [PubMed PMID: 30811954]|
|||Kozlov AI, [Carbohydrate-related nutritional and genetic risks of obesity for indigenous northerners]. Voprosy pitaniia. 2019; [PubMed PMID: 30811129]|
|||Gowd V,Xie L,Zheng X,Chen W, Dietary fibers as emerging nutritional factors against diabetes: focus on the involvement of gut microbiota. Critical reviews in biotechnology. 2019 Feb 27; [PubMed PMID: 30810398]|
|||Holly JMP,Biernacka K,Perks CM, Systemic Metabolism, Its Regulators, and Cancer: Past Mistakes and Future Potential. Frontiers in endocrinology. 2019; [PubMed PMID: 30809194]|
|||Akinkuotu AC,Hamilton JK,Birken C,Toulany A,Strom M,Noseworthy R,Hagen J,Dettmer E,Langer JC, Evolution and Outcomes of a Canadian Pediatric Bariatric Surgery Program. Journal of pediatric surgery. 2019 Feb 2; [PubMed PMID: 30808540]|
|||Mercado-Gonzales SI,Carpio-Rodríguez AN,Carrillo-Larco RM,Bernabé-Ortiz A, Sleep Duration and Risk of Obesity by Sex: Nine-Year Follow-Up of the Young Lives Study in Peru. Childhood obesity (Print). 2019 Feb 27; [PubMed PMID: 30810346]|
|||Shiozawa B,Madsen C,Banaag A,Patel A,Koehlmoos T, Body Mass Index Effect on Health Service Utilization Among Active Duty Male United States Army Soldiers. Military medicine. 2019 Feb 27; [PubMed PMID: 30811530]|
|||Al-Nimr RI, Optimal Protein Intake during Weight Loss Interventions in Older Adults with Obesity. Journal of nutrition in gerontology and geriatrics. 2019 Feb 26; [PubMed PMID: 30806592]|
|||Pasarica M,Topping D, An Evidence-Based Approach to Teaching Obesity Management to Medical Students. MedEdPORTAL : the journal of teaching and learning resources. 2017 Dec 20; [PubMed PMID: 30800862]|
|||Walsh K,Grech C,Hill K, Health advice and education given to overweight patients by primary care doctors and nurses: A scoping literature review. Preventive medicine reports. 2019 Jun; [PubMed PMID: 30805277]|
|||Ball W,Raza SS,Loy J,Riera M,Pattar J,Adjepong S,Rink J, Effectiveness of Intra-Gastric Balloon as a Bridge to Definitive Surgery in the Super Obese. Obesity surgery. 2019 Feb 26; [PubMed PMID: 30806915]|
|||Klebanoff MJ,Corey KE,Samur S,Choi JG,Kaplan LM,Chhatwal J,Hur C, Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis. JAMA network open. 2019 Feb 1; [PubMed PMID: 30794300]|
|||Monteiro JLGC,Pellizzer EP,Araújo Lemos CA,de Moraes SLD,do Egito Vasconcelos BC, Is there an association between overweight/obesity and dental implant complications? A systematic review and meta-analysis. International journal of oral and maxillofacial surgery. 2019 Feb 18; [PubMed PMID: 30792086]|
|||Barr AC,Lak KL,Helm MC,Kindel TL,Higgins RM,Gould JC, Linear vs. circular-stapled gastrojejunostomy in Roux-en-Y gastric bypass. Surgical endoscopy. 2019 Feb 25; [PubMed PMID: 30805785]|